Persistence of antienvoplakin and antiperiplakin antibodies in a patient with paraneoplastic pemphigus 20 years after remission

Br J Dermatol. 2020 Mar;182(3):797-798. doi: 10.1111/bjd.18534. Epub 2019 Nov 8.

Authors

J Riera-Monroig¹, P Iranzo¹, N Ishii², T Hashimoto^{2

3}, J M Mascaró Jr¹

Affiliations

¹ Department of Dermatology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
² Department of Dermatology, Kurume University School of Medicine and Kurume University Institute of Cutaneous Cell Biology, Fukuoka, Japan.
³ Department of Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan.

PMID: 31529517
DOI: 10.1111/bjd.18534

No abstract available

Publication types

Letter

MeSH terms

Antibodies
Humans
Paraneoplastic Syndromes*
Pemphigus* / drug therapy

Substances

Antibodies